欢迎来到《四川大学学报(医学版)》

免疫耐受的守护者:调节性T细胞

Guardians of Immune Tolerance: Regulatory T Cells

  • 摘要: 日本科学家坂口志文(Shimon Sakaguchi)、美国科学家玛丽·E·布伦科(Mary E. Brunkow)和弗雷德·拉姆斯德尔(Fred Ramsdell)因在外周免疫耐受领域的开创性发现,共同荣获2025年诺贝尔生理学或医学奖。本文对获得诺贝尔奖的免疫耐受研究进行回顾,并介绍了调节性T细胞(regulatory T cells, Treg)的发育、功能及其在疾病治疗中的应用,免疫耐受的开拓性研究凸显了一个核心的免疫学理念:健康的免疫系统不仅依赖于强大的清除病原体和突变细胞的能力,更在于精准的“刹车”与耐受机制。这一认知将加深我们对自身免疫病、移植排斥和肿瘤免疫等核心医学问题的理解,并将催生一系列靶向外周免疫耐受和Treg细胞的疾病治疗策略,有望推动精准免疫调控的研究。

     

    Abstract: Shimon Sakaguchi, a Japanese scientist, together with Mary E. Brunkow and Fred Ramsdell, American scientists, were jointly awarded the 2025 Nobel Prize in Physiology or Medicine for their pioneering discoveries in the field of peripheral immune tolerance. This review summarizes the Nobel Prize-winning research on immune tolerance and discusses the development, functions, and therapeutic applications of regulatory T cell (Treg)-based interventions. These seminal studies on immune tolerance underscore a central immunological concept—a healthy immune system relies not only on its robust capacity to eliminate pathogens and mutated cells, but also on the precise inhibitory (or “brake”) and tolerance mechanisms. This concept will help deepen our understanding of key medical challenges such as autoimmune diseases, transplant rejection, and tumor immunity. It will spur the development of a series of therapeutic strategies targeting peripheral immune tolerance and Treg cells and advance research in precision immune regulation.

     

/

返回文章
返回